medigraphic.com
ISSN 1990-7990 (Electronic)
Revista Universitaria

2021, Number 1

<< Back Next >>

Universidad Médica Pinareña 2021; 17 (1)

Cancer patient care in times of COVID-19

Luna-López AE, Germán-Flores L, Zúñiga-García ÁE

Language: Spanish
References: 28
Page: 1-8
PDF size: 395.38 Kb.


ABSTRACT

Introduction: with the emergence of the new coronavirus and the wide worldwide distribution, its effects in people with some comorbidities are a global concern. Cancer is a disease with a high incidence and prevalence in society, included among the main causes of mortality.
Objective: to describe the management of cancer patients during COVID-19.
Method: a literature review of articles published up to June 2020 was carried out, using the Pubmed / Medline, SCOPUS and SciELO databases. 28 references were selected for the preparation of the present.
Development: cancer has variable clinical and prognostic behaviors that generally lead to states of immunosuppression caused by the therapeutics used for its treatment; Therefore, they are more vulnerable to infectious diseases. The proper care of this group of people is the responsibility of the health systems. Some measures are based on social distancing, either in reducing the number of companions of the patient in the consultation or chemotherapy sessions, the prohibition of visits to hospitalized patients and the use of technologies with the use of teleconsultations for routine follow-up, as well as the change from intravenous to oral treatments.
Conclusions: the study of the behavior of COVID-19 in cancer patients is under development. The measures that the institutions take to achieve quality care for people with cancer are varied and are based mainly on social distancing.


REFERENCES

  1. Mustafa NM, A Selim L. Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis. J Clin Virol [Internet]. 2020 [citado 29/07/2020];128:104395. Disponible en: http://www.sciencedirect.com/science/article/pii/S1386653220301372

  2. Down B, Kulkarni S, Khan AHA, Barker B, Tang I. Novel coronavirus (COVID-19) infection: What a doctor on the frontline needs to know. Ann Med Surg [Internet]. 2020 [citado 29/07/2020];55:24-9. Disponible en: http://www.sciencedirect.com/science/article/pii/S2049080120300996

  3. Coronavirus disease (COVID-19) Situation Report [Internet]. World Health Organization; 2020 [citado 29/07/2020]. Report No.: 160. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200628-covid-19-sitrep-160.pdf?sfvrsn=2fe1c658_2

  4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2018 [citado 29/07/2020];68(6):394-424. Disponible en: https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.3322/caac.21492

  5. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de la Salud, 2019 [Internet]. La Habana: Dirección de Registros Médicos y Estadísticas de la Salud; 2020 [citado 15 de junio de 2020]. Disponible en: https://files.sld.cu/bvscuba/files/2020/05/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2019-ed-2020.pdf

  6. Rubinstein SM, Steinharter JA, Warner J, Rini BI, Peters S, Choueiri TK. The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer. Cancer Cell [Internet]. 2020 [citado 29/07/2020];37(6):738-41. Disponible en: http://www.sciencedirect.com/science/article/pii/S1535610820302178

  7. Lee LYW, Cazier JB, Starkey T, Turnbull CD, Kerr R, Middleton G. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. The Lancet [Internet]. 2020 [citado 29/07/2020];395(10241):1919-26. Disponible en: http://www.sciencedirect.com/science/article/pii/S0140673620311739

  8. Li L, Li R, Wu Z, Yang X, Zhao M, Liu J, et al. Therapeutic strategies for critically ill patients with COVID-19. Ann Intensive Care [Internet]. 2020 [citado 29/07/2020];10(1):1-9. Disponible en: https://annalsofintensivecare.springeropen.com/articles/10.1186/s13613-020-00661-z

  9. Di Lorenzo G, Di Trolio R. Kozlakidis Z, Busto G, Ingenito C, Buonerba L, et al. COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature. Critical Reviews in Oncology/Hematology [Internet]. 2020 [citado 29/07/2020]; 152:102991. Disponible en: https://www.sciencedirect.com/science/article/pii/S1040842820301293

  10. Pérez Abreu MRP, Gómez Tejeda JJ, Dieguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev Habanera Cienc Médicas [Internet]. 2020 [citado 29/07/2020];19(2):3254. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254

  11. Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta [Internet]. 2020 [citado 29/07/2020];508:254-66. Disponible en: http://www.sciencedirect.com/science/article/pii/S0009898120302503

  12. Slimano F, Baudoin A, Zerbit J, Cazin JL, Bardin Ch, Rioufol C, et al. Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). Cancer Treatment Review [Internet]. 2020 [citado 29/07/2020]; 88:102063. Disponible en: https://doi.org/10.1016/j.ctrv.2020.102063

  13. McCreary EK, Pogue JM. Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options. Open Forum Infect Dis [Internet]. 2020 [citado 29/07/2020];7(4). Disponible en: https://academic.oup.com/ofid/article/7/4/ofaa105/5811022

  14. Arango Prado M del C, Rodríguez-Padilla C. Protagonismo del sistema inmune en el microambiente de los tumores malignos de la mama. Rev Cuba Hematol Inmunol Hemoter [Internet]. 2016 [citado 29/07/2020];32(2):0-0. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S0864-02892016000200004&lng=es&nrm=iso&tlng=pt

  15. Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and Cancer: Friends or Faux? Int J Mol Sci [Internet]. 2020 [citado 29/07/2020];21(9):3115. Disponible en: https://www.mdpi.com/1422-0067/21/9/3115

  16. Feng M, Jiang W, Kim BYS, Zhang CC, Fu Y-X, Weissman IL. Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat Rev Cancer [Internet]. 2019 [citado 29/07/2020];19(10):568-86. Disponible en: https://www.nature.com/articles/s41568-019-0183-z

  17. Dariya B, Nagaraju GP. Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients. Cytokine Growth Factor Rev [Internet]. 2020 [citado 29/07/2020];53:43-52. Disponible en: http://www.sciencedirect.com/science/article/pii/S1359610120300782

  18. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol [Internet]. 2020 [citado 29/07/2020];31(7):894-901. Disponible en: http://www.sciencedirect.com/science/article/pii/S0923753420363833

  19. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol [Internet]. 2020 [citado 29/07/2020];21(3):335-7. Disponible en: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30096-6/abstract

  20. Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol [Internet]. 2020 [citado 29/07/2020]; Disponible en: http://www.sciencedirect.com/science/article/pii/S1470204520303107

  21. Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol [Internet]. 2020 [citado 29/07/2020];893-903. Disponible en: http://www.sciencedirect.com/science/article/pii/S1470204520303090

  22. Garassino MC, Whisenant JG, Huang L-C, Trama A, Torri V, Agustoni F, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol [Internet]. 2020 [citado 29/07/2020];21(7):914-22. Disponible en: http://www.sciencedirect.com/science/article/pii/S1470204520303144

  23. Weinkove R, McQuilten ZK, Adler J, Agar MR, Blyth E, Cheng AC, et al. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust [Internet]. 2020 [citado 29/07/2020];212(10):481-9. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.5694/mja2.50607

  24. Pramesh CS, Badwe RA. Cancer Management in India during Covid-19. The new england journal of medicine. N Engl J Med [Internet]. 2020 [citado 27/08/2020]; 382:e6 https://www.nejm.org/doi/full/10.1056/NEJMc2011595

  25. Nagar H, Formenti SC. Cancer and COVID-19 — potentially deleterious effects of delaying radiotherapy. Nat Rev Clin Oncol [Internet]. 2020 [citado 29/07/2020];17(6):332-4. Disponible en: https://www.nature.com/articles/s41571-020-0375-1

  26. Sharma DC. Lockdown poses new challenges for cancer care in India. Lancet Oncol [Internet]. 29 de mayo de 2020 [citado 29/07/2020];0(0). Disponible en: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30312-0/abstract

  27. Sharpless NE. COVID-19 and cancer. Science [Internet]. 2020 [citado 29/07/2020];368(6497):1290-1290. Disponible en: https://science.sciencemag.org/content/368/6497/1290

  28. Anil I, Arnold R, Benkwitz-Beford S, Branford S, Campton N, Cazier J-B, et al. The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19. Lancet Oncol [Internet]. 2020 [citado 29/07/2020];21(5):622-4. Disponible en: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30230-8/abstract




2020     |     www.medigraphic.com